ツイートする Facebook にシェア

Sonepiprazole

From Wikipedia, the free encyclopedia

Jump to: navigation, search
Sonepiprazole
Systematic (IUPAC) name
4-(4-{2-[(1S)-3,4-dihydro-1H-isochromen-1-yl]ethyl}piperazin-1-yl)benzenesulfonamide
Clinical data
Pregnancy cat.  ?
Legal status Uncontrolled
Routes Oral
Identifiers
CAS number 170858-34-1
ATC code None
PubChem CID 133079
ChemSpider 117441
UNII O609V24217 YesY
Chemical data
Formula C21H27N3O3S 
Mol. mass 401.52 g/mol
SMILES eMolecules & PubChem

Sonepiprazole (U-101,387, PNU-101,387-G) is a drug of the phenylpiperazine class which acts as a highly selective D4 receptor antagonist.[1] In animals, unlike D2 receptor antagonists like haloperidol, sonepiprazole does not block the behavioral effects of amphetamine or apomorphine, does not alter spontaneous locomotor activity on its own, and lacks extrapyramidal and neuroendocrine effects.[2] However, it does reverse the prepulse inhibition deficits induced by apomorphine,[3] and has also been shown to enhance cortical activity and inhibit stress-induced cognitive impairment.[4][5] As a result, it was investigated as an antipsychotic for the treatment of schizophrenia in a placebo-controlled clinical trial, but in contrast to its comparator olanzapine, no benefits were found.[6][7]

See also

References

  1. ^ TenBrink RE, Bergh CL, Duncan JN, et al. (June 1996). "(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist". Journal of Medicinal Chemistry 39 (13): 2435–7. doi:10.1021/jm960084f. PMID 8691438. 
  2. ^ Merchant KM, Gill GS, Harris DW, et al. (December 1996). "Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist". The Journal of Pharmacology and Experimental Therapeutics 279 (3): 1392–403. PMID 8968364. http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=8968364. 
  3. ^ Mansbach RS, Brooks EW, Sanner MA, Zorn SH (January 1998). "Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition". Psychopharmacology 135 (2): 194–200. doi:10.1007/s002130050501. PMID 9497025. http://link.springer.de/link/service/journals/00213/bibs/8135002/81350194.htm. 
  4. ^ Rubinstein M, Cepeda C, Hurst RS, et al. (June 2001). "Dopamine D4 receptor-deficient mice display cortical hyperexcitability". Journal of Neuroscience 21 (11): 3756–63. PMID 11356863. http://www.jneurosci.org/cgi/pmidlookup?view=long&pmid=11356863. 
  5. ^ Arnsten AF, Murphy B, Merchant K (October 2000). "The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys". Neuropsychopharmacology 23 (4): 405–10. doi:10.1016/S0893-133X(00)00133-0. PMID 10989267. 
  6. ^ Unangst PC, Capiris T, Connor DT, et al. (August 1997). "Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agents". Journal of Medicinal Chemistry 40 (17): 2688–93. doi:10.1021/jm970170v. PMID 9276014. 
  7. ^ Corrigan MH, Gallen CC, Bonura ML, Merchant KM (March 2004). "Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial". Biological Psychiatry 55 (5): 445–51. doi:10.1016/j.biopsych.2003.10.004. PMID 15023570. http://linkinghub.elsevier.com/retrieve/pii/S000632230301076X. 

gooウェブ検索 急上昇ランキング (総合)
Wikipedia記事検索について

This page is based on the copyrighted Wikipedia article ( Sonepiprazole ); it is used under the GNU Free Documentation License. You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.